Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure

Acta Pharmaceutica

Volumn 62, Issue 4, 2012, Pages 563-580

  Meena, Ashok K ^a   Sharma, Kuldeep ^b   Kandaswamy, Murugesh ^b   Rajagopal, Sriram ^b   Mullangi, Ramesh ^b  

^a Preformulation Department   (India)

^b JUBILANT BIOSYS LTD   (India)

Author keywords

Albendazole; Lipid based formulation; Pharmacokinetics; Rats; SEDDS

Indexed keywords

ALBENDAZOLE; MACROGOL 400; OIL; POLYSORBATE 80; PROPYLENE GLYCOL; SURFACTANT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; MALE; MAXIMUM PLASMA CONCENTRATION; MICROEMULSION; NONHUMAN; RAT; SELF EMULSIFYING DRUG DELIVERY SYSTEM; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84876543695     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-012-0031-0     Document Type: Article

References (39)

1. J. R. Robinson, Introduction: semi-solid formulations for oral drug delivery, Bull. Tech. Gattefosse 89 (1996) 11-13.
2. A. K. Meena, D. V. Ratnam, G. Chandraiah, D. D. Ankola, P. R. Rao and M. N. Kumar, Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia, Lipids 43 (2008) 231-241; DOI: 10.1007/s11745-007-3142-5.
3. D. V. Ratnam, G. Chandraiah, A. K. Meena, P. Ramarao and M. N. Kumar, The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats, J. Nanosci. Nanotechnol. 9 (2009) 6741-6746.
4. C. W. Pouton, Effects of the inclusion of a model drug on the performance of self-emulsifying formulations, J. Pharm. Pharmacol. 37 (1985) Suppl. 12:1P; DOI: 10.1111/j.2042-7158.1985.tb14073.
5. C. W. Pouton, Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification, Int. J. Pharm. 27 (1985) 335-348; DOI: 10.1016/0378-5173(85)90081-X. (Pubitemid 16218683)
6. C. W. Pouton, Formulation of self-emulsifying drug delivery systems, Adv. Drug. Deliv. Rev. 25 (1997) 47-58; DOI: 10.1016/S0169-409X(96)00490-5. (Pubitemid 27107790)
7. H. Shen and M. Zhong, Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin, J. Pharm. Pharmacol. 58 (2006) 1183-1191; DOI: 10.1211/jpp.58.9.0004. (Pubitemid 44329099)
8. N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld and A. W. Malick, Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, Int. J. Pharm. 106 (1994) 15-23; DOI: 10.1016/0378-5173(94)90271-2. (Pubitemid 24110060)
9. T. R. Kommuru, B. Gurley, M. A. Khan and I. K. Reddy, Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, Int. J. Pharm. 212 (2001) 233-246; DOI: 10.1016/S0378-5173(00)00614-1. (Pubitemid 32119449)
10. A. A. Kale and V. B. Patravale, Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine, AAPS Pharm. Sci. Tech. 9 (2008) 191-196; DOI: 10.1208/s12249-008-9037-9.
11. J. I. Tang, J. Sun and Z. G. He, Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs, Curr. Drug Therapy 2 (2007) 85-93. (Pubitemid 46723141)
12. P. Gao, B. D. Rush, W. P. Pfund, T. Huang, J. M. Bauer W. Morozowich, M. S. Kuo and M. J. Hageman, Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability, J. Pharm. Sci. 87 (2003) 2386-2398; DOI: 10.1002/jps.10511. (Pubitemid 37484765)
13. G. C. Cook, Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy, Parasitol. Today 6 (1990) 133-136; DOI: 10.1016/0169-4758(90)90232-S. (Pubitemid 20131124)
14. E. Galia, J. Horton and J. B. Dressman, Albendazole generics: a comparative in vitro study, Pharm. Res. 16 (1999) 1871-1875; DOI: 10.1023/A:1018907527253. (Pubitemid 30040704)
15. I. M. Rigter, H. G. Schipper, R. P. Koopmans, H. J. M. Van Kan, H. W. Frijlink, P. A. Kager and H. J. Guchelaar, Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers, Antimicrob. Agents Chemother. 48 (2004) 1051-1054; DOI: 10.1128/AAC. 48.3. 1051-1054.2004. (Pubitemid 38280368)
16. C. T. Dollery, Albendazole, in Therapeutic Drugs, 2nd ed., Churchill Livingstone, Edinburgh 1999, pp. 184-188.
17. J. J. García, F. Bolas and J. J. Torrado, Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole, Int. J. Pharm. 250 (2003) 351-358; DOI: 10.1016/S0378-5173(02) 00559-8. (Pubitemid 36084359)
18. S. Torrado, S. Torrado, R. Cadorniga and J. J. Torrado, Formulation parameters of albendazole solution, Int. J. Pharm. 140 (1996) 45-50; DOI: 10.1016/0378-5173(96)04545-0. (Pubitemid 26276713)
19. S. Torrado, M. L. López, G. Torrado, F. Bolás, S. Torrado and R. Cadórniga, A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation, Int. J. Pharm. 156 (1997) 181-187; DOI: 10.1016/S0378-5173(97)00204-4. (Pubitemid 27400006)
20. P. A. Redondo, A. I. Alvarez, J. L. García, C. Villaverde and J. G. Prieto, Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats, Biopharm. Drug Dispos. 19 (1998) 65-70. (Pubitemid 28064492)
21. H. Wen, R. R. New, M. Muhmut, J. H. Wang, Y. H. Wang, J. H. Zhang, Y. M. Shao and P. S. Craig, Pharmacology and efficacy of liposome entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine, Parasitology 113 (1996) 111-121; DOI: 10.1017/S003118200006635X. (Pubitemid 26337057)
22. S. Torrado, S. Torrado, J. J. Torrado and R. Cadórniga, Preparation, dissolution and characterization of albendazole solid dispersion, Int. J. Pharm. 140 (1996) 247-250; DOI: 10.1016/0378-5173(96)04586-3. (Pubitemid 26292771)
23. M. L. Lopez, S. Torrado, S. Torrado, A. R. Martínez and F. Bolás, Improvement of albendazole efficacy against enteral, but not against parenteral stages of Trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone, Chemotherapy 43 (1997) 430-435; DOI: 10.1159/000239602.
24. R. Kalaiselvan, G. P. Mohanta, K. Kannan, P. K. Manna and R. Manavalan, Optimization of drug-polymer mixing ratio in albendazole-polyvinylpyrrolidone solid dispersion by moisture absorption studies, Acta. Pharm. Sci. 48 (2006) 141-151. (Pubitemid 46143108)
25. J. A. Castillo, J. Palomo-Canales, J. J. Garcia, J. L. Lastres, F. Bolas and J. J. Torrado, Preparation and characterization of albendazole ?-cyclodextrin complexes, Drug. Dev. Ind. Pharm. 25 (1999) 1241-1248; DOI: 10.1081/DDC-100102294.
26. G. Piel, B. Evrard, T. Van Hees, G. Llabres and L. Delattre, Development of a parenteral and of an oral formulation of albendazole with cyclodextrins, STP. Pharma. Sci. 9 (1999) 257-260. (Pubitemid 29337080)
27. T. Mukherjee and F. M. Plakogiannis, Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole, J. Pharm. Pharmacol. 62 (2010) 1112-1120; DOI: 10.1111/j.2042-7158.2010.01149.x.
28. C. W. Pouton, Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems, Eur. J. Pharm. Sci. 11 (2000) S93-S98; DOI: 10.1016/S0928-0987(00) 00167-6.
29. V. Borhade, H. Nair and D. Hegde, Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus, AAPS Pharm. Sci. Tech. 9 (2008) 13-21; DOI: 10.1208/s12249-007-9014-8.
30. K. Sharma, M. Kandaswamy, C. Mithra, A. K. Meena, S. Giri, S. Rajagopal and R. Mullangi, Highly sensitive LC-MS/MS-ESI method for simultaenous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study, Biomed. Chromatogr. 26 (2011) 247-255; DOI: 10.1002/bmc.1654.
31. H. Jung, M. Hurtado, M. Sanchez, M. T. Medina and J. Sotelo, Clinical pharmacokinetics of albendazole in patients with brain cysticercosis, J. Clin. Pharmacol. 32 (1992) 28-31.
32. J. Sotelo and H. Jung, Pharmacokinetic optimization of treatment of neurocysticercosis, Clin. Pharmacokinet. 34 (1998) 503-515.
33. O. M. Takayanagui, V. L. Lanchote, M. P. Marques and P. S. Bonato, Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone, Ther. Drug Monit. 19 (1997) 51-55. (Pubitemid 28068995)
34. M. J. Groves, The self-emulsifying action of mixed surfactants in oil, Acta. Pharm. Suec. 13 (1976) 361-372.
35. J. H. Schulman and J. B. Montagne, Formation of microemulsions by amino alkyl alcohols, Ann. NY Acad. Sci. 92 (1961) 366-371; DOI: 10.1111/j.1749-6632. 1961. tb44987.x
36. N. Kohri, Y. Yamayoshi, K. Iskei, N. Sato, S. Todo and K. Miyazaki, Effect of gastric pH on the bioavailability of albendazole, Pharm. Pharmacol. Commun. 4 (1998) 267-270; DOI: 10.1111/j.2042-7158.1998.tb00692.x.
37. G. C. Cook, Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy, Parasitol. Today 6 (1990) 133-136; DOI: 10.1016/0169-4758(90)90232-S. (Pubitemid 20131124)
38. W. Warisnoicharoen, A. B. Lansley and M. J. Lawrence, Nonionic oil-in-water microemulsions: effect of oil type on phase behavior, Int. J. Pharm. 198 (2000) 7-27; DOI: 10.1016/S0378-5173(99)00406-8. (Pubitemid 30155546)
39. C. Malcolmson, A. Sidhu, C. Satra, S. Kantaria and M. J. Lawrence, Effect of the nature of oil on the incorporation of testosterone propionate into nonionic oil-in-water microemulsions, J. Pharm. Sci. 87 (1998) 109-116. (Pubitemid 28079271)